Our data showed that lincRNA-p21 and β-catenin levels in GBM cells and tissues were inversely correlated, which suggested that lincRNA-p21 might negatively regulate β-catenin signal activity in GBM cells, particularly in GSCs. The gene discussed is CDKN1A; the disease is glioblastoma.